STAT

Opinion: Contraception is quietly under siege at the Department of Health and Human Services

The Trump administration owes all Americans answers to questions about what is going on at HHS. We aren't holding our breath for its reply, but are doing something about it.

In mid-January, anti-abortion activist Teresa Manning Wagner, the deputy assistant secretary for the Office of Population Affairs in the Department of Health and Human Services, was after supposedly resigning her post. Her acting replacement, Valerie Huber, has working against birth control programs and advocating for abstinence-only programs; she had no government experience before joining HHS last summer. HHS is in publishing guidelines for the Title X grant program that provides free and low-cost birth control to 4 million low-income people annually. And to make matters worse,.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks